Found: 8
Select item for more details and to access through your institution.
Peripherally administered antibodies against amyloid B-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.
- Published in:
- Nature Medicine, 2000, v. 6, n. 8, p. 916, doi. 10.1038/78682
- By:
- Publication type:
- Article
mRNA knockdown by single strand RNA is improved by chemical modifications.
- Published in:
- Nucleic Acids Research, 2012, v. 40, n. 9, p. 4125, doi. 10.1093/nar/gkr1301
- By:
- Publication type:
- Article
APP-selective gamma secretase inhibitor ELND006 effects on brain parenchymal and vascular amyloid beta in the PDAPP mouse model of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Pharmacokinetic and pharmacodynamic analysis of a novel gamma secretase inhibitor in a nontransgenic A-beta mouse efficacy model
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Pharmacokinetic and pharmacodynamic analysis of a novel gamma secretase inhibitor in a non-transgenic A-beta mouse efficacy model
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 2, p. 55, doi. 10.1159/000112832
- By:
- Publication type:
- Article
Prevention and Reduction of AD-type Pathology in PDAPP Mice Immunized with Aβ<sub>1-42</sub>.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 920, n. 1, p. 274, doi. 10.1111/j.1749-6632.2000.tb06936.x
- By:
- Publication type:
- Article
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
- Published in:
- Nature, 1999, v. 400, n. 6740, p. 173, doi. 10.1038/22124
- By:
- Publication type:
- Article